Evidence map›Paper›PMID 40920869›Full record

ArticlePLoS neglected tropical diseases2025

The prevalence of trachoma, ocular Chlamydia trachomatis infection and anti-Pgp3 antibodies in Choiseul Province, Solomon Islands.

Clare E F Dyer, Carleigh S Cowling, Oliver Sokana, Lazarus Neko, Nemia Bainivalu, Freda Pitakaka, Anasaini Cama, Mitchel Starr, Emma M Harding-Esch, Cristina Jimenez and 6 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Clare E F DyerThe Kirby Institute, University of New South Wales, Sydney, Australia.
Carleigh S CowlingThe Kirby Institute, University of New South Wales, Sydney, Australia.ORCID 0009-0005-8539-1083
Oliver SokanaMinistry of Health and Medical Services, Honiara, Solomon Islands.
Lazarus NekoMinistry of Health and Medical Services, Honiara, Solomon Islands.
Nemia BainivaluMinistry of Health and Medical Services, Honiara, Solomon Islands.
Freda PitakakaMinistry of Health and Medical Services, Honiara, Solomon Islands.
Anasaini CamaThe Fred Hollows Foundation, Melbourne, Australia.
Mitchel StarrNew South Wales State Reference Laboratory for HIV, St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia.
Emma M Harding-EschLondon School of Hygiene & Tropical Medicine, London, United Kingdom.
Cristina JimenezSightsavers, Haywards Heath, United Kingdom.
Ana BakhtiariInternational Trachoma Initiative, The Task Force for Global Health, DecaturUnited States of America.
Sarah BoydInternational Trachoma Initiative, The Task Force for Global Health, DecaturUnited States of America.
Sara WebsterThe Fred Hollows Foundation, Melbourne, Australia.
Anthony W SolomonGlobal Neglected Tropical Diseases Programme, World Health Organization, Geneva, Switzerland.
John M KaldorThe Kirby Institute, University of New South Wales, Sydney, Australia.
Susana Vaz NeryThe Kirby Institute, University of New South Wales, Sydney, Australia.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Trachoma, caused by repeated ocular infection with Chlamydia trachomatis, remains a leading infectious cause of blindness globally, with significant implications for public health. The World Health Organization and partners aim to eliminate trachoma as a public health problem by 2030, targeting specific prevalence thresholds for trachomatous trichiasis (TT) and trachomatous inflammation-follicular (TF). Diagnosis is primarily clinical. Studies have shown discrepancies between prevalence estimates of TF and C. trachomatis infection. This study, undertaken in Choiseul, Solomon Islands, evaluated TF, evidence of current C. trachomatis infection (by polymerase chain reaction (PCR) on conjunctival swabs), and evidence of past exposure to that bacterium (using anti-Pgp3 serology on dried blood spots). Among 645 1-9-year-old children, TF prevalence was 17.5% and C. trachomatis prevalence was 8.5%. These findings suggest transmission of sufficient intensity to pose a public health problem. Notably, 59% of children with TF had evidence of neither current nor previous C. trachomatis infection. Increasing age was associated with TF and evidence of past infection, but not current infection. The community had poor water, sanitation, and hygiene conditions. This study highlights the benefit of integrating laboratory testing for guiding effective trachoma elimination as a public health problem. Although our work was limited by imperfect enrolment of resident children and the logistical challenges of collecting samples in a remote region, we believe our data justify continued public health interventions against trachoma in Choiseul.

Indexed as

Antibodies, BacterialAntigens, BacterialBacterial ProteinsChlamydia trachomatisTrachomaChildChild, PreschoolFemaleHumansInfantMaleMelanesiaPrevalenceTrichiasisAntibodies, BacterialAntigens, BacterialBacterial Proteinspgp3 protein, Chlamydia

Identifiers

PMID40920869
PMCPMC12425259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.